Top Story

JAK inhibitors for hair loss receive US patents

September 5, 2017

The US patent office has issued two patents for janus kinase inhibitors for hair loss, according to a press release from Aclaris Therapeutics.

One of the patents includes coverage for tofacitinib, baricitinib (Olumiant, Incyte & Lilly), ruxolitinib (Jakafi, Incyte) and decernotinib (KareBay Biochem) as therapeutic options for androgenetic alopecia, or pattern hair loss. There are 22 claims in this patent, according to the statement.

In the Journals

Pubic hair grooming injuries common in US adults

August 17, 2017
The frequency and degree of pubic hair grooming, in terms of the amount of hair removed, was associated with increased likelihood of injury. The aim of the web-based…
In the Journals

Two histopathologic patterns found in cutaneous lupus of the scalp

August 14, 2017
Histopathologic assessment of hair follicles in patients with chronic cutaneous lupus erythematosus of the scalp revealed two distinct patterns, according to recent…

Top five dermatology stories in July include psoriasis studies, FDA approval

July 31, 2017
Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in…
More Headlines »